Q1 2018 Holdings
Filed 2018-05-14 | 187 holdings | $261.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $103.7M | 378,703 | 39.7% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $42.7M | 450,738 | 16.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $22.8M | 281,076 | 8.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $15.5M | 130,376 | 5.9% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $12.5M | 457,585 | 4.8% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $10.7M | 272,400 | 4.1% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $9.6M | 855,468 | 3.7% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $8.9M | 283,250 | 3.4% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $8.3M | 49,496 | 3.2% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $7.5M | 265,045 | 2.9% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $3.2M | 639,370 | 1.2% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $3.1M | 38,931 | 1.2% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $2.4M | 22,670 | 0.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $2.1M | 93,689 | 0.8% |
| Coherus BioSciences, Inc.(CHRS) | Common | 19249H103 | $2.0M | 181,023 | 0.8% |
| Akebia Therapeutics, Inc.(AKBA) | Common | 00972D105 | $1.3M | 132,849 | 0.5% |
| Cytokinetics, Incorporated(CYTK) | Common | 23282W605 | $992.0K | 137,797 | 0.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $808.0K | 203,935 | 0.3% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $406.0K | 6,214 | 0.2% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $230.0K | 2,810 | 0.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $155.6K | 2,063,699 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $120.7K | 1,352,842 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $119.4K | 700,588 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $114.4K | 893,082 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $100.1K | 614,084 | 0.0% |
| Unitedhealth Group Incorporated(UNH) | Common | 91324P102 | $75.4K | 352,317 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $72.8K | 2,051,943 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $71.1K | 1,726,967 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $69.9K | 1,284,022 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $69.7K | 294,892 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $55.6K | 498,975 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $53.8K | 645,442 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $48.1K | 139,560 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $47.9K | 798,619 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $41.9K | 522,211 | 0.0% |
| Allergan plc | Shares | G0177J108 | $41.9K | 248,836 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $37.7K | 486,865 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $33.3K | 525,722 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $31.9K | 118,733 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $30.5K | 147,855 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $29.3K | 153,076 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $28.4K | 351,020 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $28.0K | 378,516 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $24.6K | 230,158 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $23.2K | 279,419 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $22.8K | 366,521 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | S&P Biotech ETF | 78464A870 | $22.0K | 250,460 | 0.0% |
| Anthem, Inc.(ELV) | Common | 036752103 | $20.1K | 91,482 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | Common | 78667J108 | $20.1K | 124,650 | 0.0% |
| Teva Pharmaceutical Industries Limited(TEVA) | Sponsored ADR | 881624209 | $18.5K | 1,083,223 | 0.0% |